MENU
DRMA
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Dermata Therapeutics (DRMA) Earnings Date & Reports

Dermata Therapeutics Inc develops and commercializes dermatology products for the treatment of common skin conditions... Show more

A.I. Advisor
published Earnings

DRMA is expected to report earnings to fall 24.32% to -56 cents per share on March 31

Dermata Therapeutics DRMA Stock Earnings Reports
Q4'26
Est.
$-0.56
Q2'26
Missed
by $0.19
Q1'26
Beat
by $1.02
Q4'25
Missed
by $1.02
Q3'25
Missed
by $1.33
The last earnings report on August 11 showed earnings per share of -74 cents, missing the estimate of -55 cents. With 36.77K shares outstanding, the current market capitalization sits at 3.79M.